HOME  | CONTACT  | PATIENT LOGIN  | CLINIC LOGIN  | FAQ
  • PATIENTS &
    HEALTHY VOLUNTEERS
  • INVESTIGATORS
  • CROS / SPONSORS
  • CAREERS
  • TRIAL ALERTS

TRIALS SEARCH
      
  • HEALTH NEWS

  • RSS FEEDS

  • ABOUT TRIALS

  • LINK TO US


View Clinical Trial (Medical Research Study)


Prostate Cancer Recovery Enhancement for African American Men and Their Intimate Partners

This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials

Signup
Browse Studies

City:   Greenville
State:   North Carolina
Zip Code:   27834
Conditions:   Cancer Survivor - Depression - Gastrointestinal Complications - Male Erectile Disorder - Prostate Cancer - Psychosocial Effects of Cancer and Its Treatment - Urinary Complications
Purpose:   RATIONALE: Telephone counseling after radical prostatectomy may help African American prostate cancer survivors and their intimate partners cope with the problems and challenges of surgery, and may reduce distress and improve quality of life. It is not yet known which counseling and education program is more effective in helping prostate cancer survivors and their partners. PURPOSE: This randomized clinical trial is studying effective ways to help African American prostate cancer survivors and their partners cope with challenges after surgery for early-stage prostate cancer.
Study Summary:   OBJECTIVES: Primary - To develop more effective ways to help both African American prostate cancer survivors and their intimate partners cope with the problems and challenges experienced after radical prostatectomy for prostate cancer. - To evaluate the efficacy of a new, telephone-based, partner-assisted, coping skills training (CST) protocol for reducing survivor and partner disease-related and overall distress, addressing cancer-related strain and overall distress in survivors' intimate partners, and improving relationship quality between survivors and partners by enhancing intimacy and adjustment within the relationship. Secondary - To identify for whom the intervention may be more or less efficacious by exploring the association between initial relationship functioning (i.e., dyadic adjustment scores reported by survivors and partners) and survivor outcomes and between initial relationship functioning and partner outcomes. OUTLINE: Survivors are stratified according to symptom severity (low vs moderate vs high) and clinical risk category (low vs moderate vs high). Survivor/partner dyads are randomized to 1 of 3 intervention arms. - Arm I (Partner-assisted coping skills training [PA-CST]): Survivor/partner dyads undergo a telephone-based, culturally sensitive PA-CST intervention in six weekly telephone sessions (60-minutes each) over 8 weeks, conducted by African American doctoral level clinical psychologists knowledgeable about prostate cancer and experienced in CST and cancer education. During these sessions, participants are trained in a variety of cognitive and behavioral skills to manage symptom-related distress and to improve their quality of life after prostate cancer treatment. Among these skills are strategies for communication (i.e., effective speaking and listening); behavioral coping methods (i.e., activity pacing, applied relaxation techniques, and goal setting to increase pleasant activities); and skills for managing negative mood and reducing emotional stress. Participants also receive guidance in working cooperatively with their partners to improve symptom management, including joint practicing of coping skills and problem-solving strategies. - Arm II (Cancer education): Survivor/partner dyads undergo a telephone-based, culturally sensitive cancer education intervention in six weekly telephone sessions (60 minutes each) over 8 weeks, conducted by African American doctoral level clinical psychologists knowledgeable about prostate cancer and experienced in CST and cancer education. During the sessions, participants are educated about symptoms commonly experienced after prostatectomy (i.e., erectile dysfunction, urinary incontinence, nutrition, bowel problems, and fatigue) and medical treatment options for these symptoms. Participants also receive written materials about these information. - Arm III (Wait-list control): Survivor/partner dyads receive usual care and are placed on a wait-list. After completing the study, survivors and their partners have the option of participating in either the CST or cancer education interventions. All participants complete questionnaires at baseline, right after intervention (2 months), and 3 months after intervention (5 months). Survivors complete questionnaires over approximately 28 minutes to measure symptom distress/severity, depressed mood, quality of life, self-efficacy for symptom management, relationship quality, and coping strategies. Partners complete questionnaires over approximately 17 minutes to measure caregiver strain, depressed mood, partners' self-efficacy for symptom control, relationship quality, and coping strategies. At each evaluation, physicians provide ratings of illness severity, documentation of medical treatments for cancer and symptom management, and frequency of clinic visits for each survivor.
Criteria:   DISEASE CHARACTERISTICS: - African American prostate cancer survivor - Diagnosis of early-stage prostate cancer - Stage T1-T3 disease - No regional or metastatic prostate cancer - Underwent radical prostatectomy as the primary treatment for prostate cancer within the past 2 years - Prior adjunctive radiotherapy secondary to surgery allowed - No radiotherapy (i.e., external beam radiation or brachytherapy) as primary form of treatment - Intimate partner of cancer survivor - Spouse or any cohabiting intimate partner identified by the survivor - Same sex partners and partners of all ethnicities allowed PATIENT CHARACTERISTICS: - No dementia or unstable psychiatric condition - No significant hearing impairment - Fluent in English PRIOR CONCURRENT THERAPY: - See Disease Characteristics
NCT ID:   NCT00869739
Primary Contact:   Principal Investigator
Lisa C Campbell, PhD
East Carolina University

Backup Contact:   N/A
Location Contact:   Greenville, North Carolina 27834
United States



There is no listed contact information for this specific location.

Site Status: N/A

Data Source:   ClinicalTrials.gov
Date Processed:   May 18, 2013
Modifications to this listing:   Only selected fields are shown, please use the link below to view all information about this clinical trial.
Click to view Full Listing


  • NEARBY STUDIES

Within 25 Miles

Within 50 Miles

Irritable Bowel Syndrome (with diarrhea) - Kinston NC

Within 100 Miles

Smoking - Durham NC

Ulcerative Colitis - Raleigh NC

Arthritis and Heart Disease - Raleigh NC

COPD (Chronic Obstructive Pulmonary Disease) - Raleigh NC

Asthma - Raleigh NC

Investigational Contraceptive Gel - Raleigh NC

Crohn's Disease - Raleigh NC

Nocturia - Raleigh NC

Mechanistic Evaluations of Pre-Cessation Therapies for Smoking Cessation - Durham NC

Gout - Raleigh NC

Chronic Constipation - Raleigh NC

Smoke Cessation Study (Stop Smoking) - Raleigh NC

Gout - Raleigh NC

Gout - Raleigh NC

Intolerance to Gout Medication - Raleigh NC

Irritable Bowel Syndrome w/ Diarrhea - Raleigh NC

Migraine Headaches in Teens and Adolescents - Raleigh NC

Bladder Pain (Interstitial Cystitis) - Raleigh NC

Diabetic Gastroparesis - Raleigh NC

Irritable Bowel Syndrome with Diarrhea - Raleigh NC

Bowel Prep - Raleigh NC

High LDL (Cholesterol) - Raleigh NC

Post-Shingles Pain (Postherpetic Neuralgia) - Raleigh NC

Rosacea - Raleigh NC

Endometriosis - Raleigh NC

Melanoma Vaccine - Raleigh NC

Narcolepsy - Raleigh NC

Anal Fissures - Raleigh NC

Celiac Disease - Raleigh NC

Chronic Cough - Raleigh NC

Irritable Bowel Syndrome with Diarrhea (IBS-D) - Cary NC

Irritable Bowel Syndrome with Diarrhea (IBS-D) - Raleigh NC

Rheumatoid Arthritis - Raleigh NC

Crohn's Disease - Durham NC

Hypertriglyceridemia - Raleigh NC

Fibromyalgia - Raleigh NC

Warts - Raleigh NC

Osteoarthritis of the Knee - Raleigh NC

Gastroparesis - Raleigh NC

Flu - Raleigh NC

Irritable Bowel Syndrome with Constipation - Raleigh NC

Post-Shingle Pain - Raleigh NC

Type II Diabetes with Cardio Risk - Raleigh NC

Type II Diabetes - Raleigh NC

Excessive Daytime Sleepiness with Narcolepsy - Raleigh NC

Restless Legs Syndrome (RLS) - Raleigh NC

Male Smokers - Durham NC

Irritable Bowel Syndrome (with diarrhea) - Suffolk VA

Irritable Bowel Syndrome (with diarrhea) - Raleigh NC

Irritable Bowel Syndrome (with diarrhea) - Raleigh NC

Irritable Bowel Syndrome (with diarrhea) - Fayetteville NC

High Cholesterol and Statin Therapy - Raleigh NC

Lower Back Pain Radiating to the Legs - Raleigh NC

Multiple Sclerosis - Chapel Hill NC

Chronic Constipation - Raleigh NC

Acne Rosacea - Raleigh NC

Irritable Bowel Syndrome with Diarrhea (IBS-D) - Chapel Hill NC

Irritable Bowel Syndrome (with diarrhea) - Durham NC

Sexual Issues for Women - Raleigh NC

Chronic Idiopathic Constipation - Raleigh NC

Arthritis - Raleigh NC

Diabetes (with Asthma, Emphysema or Chronic Bronchitis) - Morehead City NC

Uncontrolled Angina (Adult Stem Cell Research) - Durham NC

 
Clinical Connections Home | Investigators | CROs / Sponsors | Clinical Trials Notification | Search Clinical Trials | About Clinical Trials | Links | Terms And Conditions | Sitemap | Suggestions / Feedback
© 1998-2013 | All trademarks are property of their legal owners. | All Rights Reserved

ClinicalConnection.com is a resource that provides individuals with information regarding clinical trials that are being conducted worldwide.

ClinicalConnection.com does not conduct these clinical trials nor endorse them. Please consult your doctor or physician before participating.